The burgeoning hemp industry stands poised for explosive growth if the federal government undertakes the crucial step of rescheduling cannabis. Currently, its classification as a Schedule I drug creates massive barriers to innovation, limits banking and investment options, and perpetuates unjust policies. Rescheduling might unlock a "Green Rush," g